• Tricine-SDS-PAGE Kit Overview

  2026-10-06

  APExBIO’s K4136 is a research-use gel preparation kit described for conceptual separation of low-molecular-weight proteins and peptides. No matched peer-reviewed paper evidence was available, so performance claims remain supplier-reported.

• GABRA1 Frameshift Variants and GABAA Proteostasis

  2026-10-06

  This bioRxiv preprint examines four clinical GABRA1 frameshift variants and shows that each disrupts GABAA receptor surface trafficking and channel function through variant-specific proteostasis defects. Its main contribution is linking transmembrane-helix loss with endoplasmic-reticulum retention and uneven activation of the unfolded protein response, while defining the limits of evidence from a HEK293T cell model.

• CMC Lessons for Translating mRNA-LNP Medicines

  2026-10-05

  This 2026 review frames mRNA–lipid nanoparticle translation as a connected chemistry, manufacturing, and controls problem rather than a formulation-only challenge. Its central contribution is a CMC-oriented framework linking lipid chemistry, process behavior, critical quality attributes, analytical characterization, stability, and future scale changes to clinical and regulatory readiness.

• Dabigatran Evidence for Thromboembolic Disorders

  2026-10-05

  This 2015 review synthesizes the pharmacology, clinical evidence, and safety considerations surrounding dabigatran, an oral direct thrombin inhibitor and early non-vitamin K oral anticoagulant. Its main contribution is an integrated interpretation of randomized evidence showing efficacy across several thromboembolic settings while emphasizing renal elimination, bleeding management, and the limits of applying trial findings across patient groups.

• CGP 55845 Hydrochloride in Astrocyte Signaling

  2026-10-04

  CGP 55845 hydrochloride offers a selective pharmacological lens for separating GABAB receptor signaling from astrocytic GAT-3 regulation. This article interprets its value for synaptic transmission research while defining what the dentate gyrus evidence does—and does not—establish.

• WNT5a–GSK3–β-Catenin Control of FAP Adipogenesis

  2026-10-03

  The reference study identifies the WNT5a/GSK3/β-catenin axis as an important regulator of adipogenic drift in skeletal-muscle fibro/adipogenic progenitors (FAPs). By integrating pharmacological, single-cell, cytometric, and network-level evidence, it connects impaired WNT5a signaling with fatty degeneration and altered support of muscle regeneration.

• hsa_circ_0001944, FXR/TLR4, and Ferroptosis

  2026-10-01

  A 2025 Toxics study identifies hsa_circ_0001944 as a regulatory component linking FXR/TLR4 signaling and ferroptosis during nickel oxide nanoparticle-induced collagen deposition in LX-2 hepatic stellate cells. The work positions FXR activation as a mechanistic tool for studying toxicant-associated fibrosis while clarifying that the findings remain primarily cellular and require in vivo validation.

• CHIR-99021 (CT99021) HCl Protocol Guide

  2026-10-01

  CHIR-99021 (CT99021) HCl is a research tool for experimentally perturbing GSK-3α/β in stem-cell, signaling, metabolic, and T-cell workflows. It can support pathway and dose-response studies, but without directly matched paper evidence it should not be treated as a universal cellular dose, clinical treatment, or validated substitute for model-specific optimization.

• Indazole and Indole Glucagon Receptor Antagonists

  2026-10-01

  This 2015 Bioorganic & Medicinal Chemistry Letters study describes a scaffold expansion from the pyrazole-based glucagon receptor antagonist MK-0893 to indazole- and indole-derived compounds. Structure–activity relationship studies identified potent candidates with favorable in vitro and rat pharmacokinetic profiles, while GRA 16d demonstrated oral activity in human glucagon receptor mouse models.

• Chronic Cabozantinib Adaptation in RCC

  2026-09-30

  This 2026 study uses quantitative phosphoproteomics to show that acute and chronic Cabozantinib exposure remodel renal cell carcinoma signaling on different timescales. Chronic treatment maintained suppression of activating MET phosphorylation while selectively reshaping adhesion-, stress-, and MAPK/AP-1-associated programs linked to modest, context-dependent motility changes.

• Tunable Human Intestinal Organoids: Study Analysis

  2026-09-29

  Yang and colleagues developed a human small-intestinal organoid system that maintains substantial proliferation while expanding epithelial cell diversity under a unified culture strategy. The study shows that stemness-enhancing pathway modulation can increase differentiation competence, while Wnt, Notch, BMP, and BET-directed interventions provide reversible or lineage-biased control.

• IWP-L6: Mapping Wnt Signals to Bone Metabolism

  2026-09-29

  Wnt biology is moving from pathway description toward causal, translationally testable mechanism. This article examines how IWP-L6, a potent Porcupine inhibitor, can help researchers connect Porcn-dependent Wnt ligand maturation with O-GlcNAcylation, PDK1 stability, aerobic glycolysis, developmental patterning, and osteogenic outcomes—while distinguishing established evidence from forward-looking experimental strategy.

• Indomethacin as a Mechanism-Dissection Tool

  2026-09-28

  Indomethacin is more than a conventional nonsteroidal anti-inflammatory drug: it can help separate cyclooxygenase, nuclear-receptor, and membrane mechanisms in inflammation research. This article connects those assay decisions to recent FXR–KLF11–JAK2/STAT3 findings in contrast-induced kidney injury without conflating distinct pharmacological systems.

• AO/PI Double Staining Kit for Melanoma Research

  2026-09-28

  Use Acridine Orange and Propidium Iodide staining to distinguish viable, apoptotic, and membrane-compromised cells in a single fluorescence workflow. This practical guide connects the AO/PI readout to melanoma drug studies, including chloroquine–everolimus experiments, while highlighting controls and interpretation limits.

• CHIR-99021 in Corneal Cell Differentiation

  2026-09-27

  A two-stage, timed differentiation strategy uses CHIR-99021 (CT99021) to help direct human iPSCs toward neural crest cells before shifting the signaling environment to generate corneal endothelial-like cells. This guide separates findings reported in the reference study from practical optimization suggestions for improving reproducibility and interpreting cell identity.

534 records 1/36 page Next 12345 下5页 Last page